Latest Articles

Publication Date
Gesynta’s endometriosis candidate enters phase 2 - European Medical Journal

Gesynta’s endometriosis candidate enters phase 2 European Medical Journal

Published: March 27, 2026, 9:57 a.m.
Gesynta’s endometriosis candidate enters phase 2 - emjreviews.com

Gesynta’s endometriosis candidate enters phase 2 emjreviews.com

Published: March 27, 2026, 9:57 a.m.
Silent endometriosis: When symptoms are mild, but the disease isn’t - Moneycontrol.com

Silent endometriosis: When symptoms are mild, but the disease isn’t Moneycontrol.com

Published: March 27, 2026, 9:52 a.m.
Revealing the immune landscape of menstrual blood: unlocking insights into activation, exhaustion, and mitochondrial mass for reproductive health.

Reproductive disorders such as endometriosis and polycystic ovary syndrome (PCOS) are increasingly recognized as immune-mediated conditions, yet their immunopathology remains poorly understood. Menstrual blood, a noninvasive and biologically relevant sample, …

Published: March 27, 2026, midnight
"Consensus-Based Management of Endometriosis-Associated Pelvic Pain: Results of a French Delphi Study".

To develop best practice guidelines under the auspices of the CNGOF (National college of French Gynaecologist Obstetrician) and Convergences PP (Convergences in Pelviperineal Pain) for the management of endometriosis-associated pelvic …

Published: March 27, 2026, midnight
BioInvent Secures €1 Million Milestone as Endometriosis Antibody Enters Phase 3 - TipRanks

BioInvent Secures €1 Million Milestone as Endometriosis Antibody Enters Phase 3 TipRanks

Published: March 26, 2026, 3:02 p.m.
It takes a decade to diagnose this disease in women, a keyhole surgery is the only way to find out - Deccan Herald

It takes a decade to diagnose this disease in women, a keyhole surgery is the only way to find out Deccan Herald

Published: March 26, 2026, 3 p.m.
BioInvent receives 1 million euro milestone payment for Phase 3 trial of HMI-115 in endometriosis - marketscreener.com

BioInvent receives 1 million euro milestone payment for Phase 3 trial of HMI-115 in endometriosis marketscreener.com

Published: March 26, 2026, 2:29 p.m.
BioInvent achieves Phase 3 milestone for HMI-115 in endometriosis - TradingView

BioInvent achieves Phase 3 milestone for HMI-115 in endometriosis TradingView

Published: March 26, 2026, 2:27 p.m.
Millions of People Suffer from a Mysterious Disease. Doctors Are Finally Learning Its Secrets. - AOL.com

Millions of People Suffer from a Mysterious Disease. Doctors Are Finally Learning Its Secrets. AOL.com

Published: March 26, 2026, 1:48 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!